# Phase15-BI System Purpose / Phase15 Purpose Alignment Holistic Review

## 1. Executive Summary

Phase15-BI stopped implementation and Acceptance execution to review whether current Phase15 work still aligns with the original purpose of AI Fund Lab v2 and Phase15.

Final judgment:

```text
PHASE15_PURPOSE_ALIGNMENT_PASS_WITH_CONDITIONS
```

Reason:

- Phase15 is still aligned with the core system purpose: a Production-quality, continuously operable Japanese equity AI trading system.
- Runtime v2 is increasingly acting as a control layer, not an AI decision substitute.
- Evidence, Safety, Policy, Temporal freshness, Broker boundaries, and Human Review are now connected as Runtime contracts.
- The current accepted scope is still limited: Step0 review-only readiness and Step1 SELL/HOLD review-only Morning.
- Full BUY Morning, Submit, Execution, Broker Write, Current apply, Notification send, Multi-Day Validation, and Production Ready are not accepted.

This review did not run Acceptance, Submit, Execution, Broker Write, or any Runtime mutation.

## 2. Read Documents

Read:

- `docs/02_architecture/runtime_architecture_v2.md`
- `docs/02_architecture/runtime_temporal_freshness_contract.md`
- `docs/phase_reports/phase15_final_summary_and_runtime_acceptance_handoff.md`
- `docs/phase_reports/phase15_ba_runtime_acceptance_holistic_review.md`
- `docs/phase_reports/phase15_bb_runtime_acceptance_step0_evidence_retry.md`
- `docs/phase_reports/phase15_bc_runtime_acceptance_step0_blocker_fix_and_retry.md`
- `docs/phase_reports/phase15_bd_runtime_acceptance_step0_remaining_blocker_resolution.md`
- `docs/phase_reports/phase15_be_runtime_acceptance_step0_final_contract_closure.md`
- `docs/phase_reports/phase15_bf_broker_authenticity_account_alignment_closure.md`
- `docs/phase_reports/phase15_bg_human_safety_review_4591.md`
- `docs/phase_reports/phase15_bh_runtime_acceptance_step1_sell_hold_review_only_morning.md`

## 3. Purpose Alignment

AI Fund Lab v2 purpose:

```text
日本株を対象とした現物AI運用システムを、
Production品質で継続運用可能にすること
```

Phase15 purpose:

```text
Runtime v2をProduction運用可能な制御システムへ成熟させ、
Runtime Acceptanceを通してその品質をEvidence付きで証明すること
```

Assessment:

| Viewpoint | Judgment | Evidence |
|---|---|---|
| RuntimeがAI判断を代行していないか | `PASS_WITH_REVIEW_NOTE` | Candidate / Opportunity / PM / Safety are formal producers. BH uses PM AI output for SELL/HOLD review. However review-only scaffolding must not become hidden SELL logic. |
| Runtimeが制御層になっているか | `PASS` | Architecture fixes Submit source, Pending lifecycle, Safety action scope, Broker boundary, Current temporal state. |
| Evidence中心か | `PASS` | BB-BH repeatedly gate progress on Market, Quote, Broker, Current, Feature, Safety, Pending, Human Review evidence. |
| Production運用目的か | `PASS_WITH_CONDITIONS` | Broker authenticity, temporal freshness, no-fill valuation, and data readiness are Production-oriented. Production Broker Write and scheduler/notification/recovery remain outside current acceptance. |
| ReviewがRuntime停止ではなく運用フローか | `PASS` | BG/BH convert valid `HIGH_RISK_REVIEW` into SELL/HOLD review-only operation while keeping BUY/Submit/Broker Write blocked. |
| SafetyがRuntimeへ接続されているか | `PASS` | Safety Decision remains `REVIEW_REQUIRED`; action scope allows SELL/HOLD review only and blocks write paths. |

Conclusion:

Phase15 has not drifted into AI accuracy work. It is mostly doing the right kind of hardening: making Runtime prove that AI, Policy, Safety, Broker, Current, and Operator review are connected by explicit contracts.

## 4. Scope Creep Review

Classification:

| Added / matured area | Classification | Reason |
|---|---|---|
| Runtime State | `Phase15に必要だった` | Safety/Data Readiness require a current operation-state authority. Ambiguity would make Acceptance unverifiable. |
| Pending Lifecycle | `Phase15に必要だった` | Stale approved pending can cause duplicate Submit or date mixing. This is core Runtime safety. |
| Data Readiness | `Phase15に必要だった` | Morning/SELL/Submit must not start from missing or stale evidence. |
| Feature Consumer Readiness | `Phase15に必要だった` | Phase15-AJ showed that artifact existence did not mean Candidate/Opportunity/PM could consume it. |
| Runtime Temporal / Freshness Contract | `Phase15に必要だった` | `Current.as_of == business_date` was false for no-fill and valuation-only cases. |
| Market / Quote Evidence | `Phase15に必要だった` | Safety, valuation, and feature freshness need formal producer evidence. |
| Current Position / Valuation split | `Phase15に必要だった` | Production operation needs no-fill valuation without changing ownership state. |
| Broker Authenticity | `Production前なら必要` and Step0-relevant | Real API vs mock/fixture ambiguity directly affects Safety/Submit trust. It was appropriate to close before moving forward. |
| Broker account alignment | `Production前なら必要` | The original full-account equality check overreached. BF correctly narrowed it to Runtime-owned reconciliation scope. |
| Human Review | `Production前なら必要`, Phase15で正当化 | Valid high-risk events need a governed review artifact. Without it, REVIEW_REQUIRED becomes a dead end. |
| Review-only Morning | `Production前なら必要`, Phase15で条件付き正当化 | Larger than pure Step1 retry, but justified because Safety blocks BUY/full Morning while SELL/HOLD review evidence is operationally necessary. |
| Notification delivery ledger | `将来改善 / Production前必須` | Payload-only is enough for Phase15 evidence, not enough for Production operation. |
| Operator dashboard | `将来改善` | Useful but not needed for Phase15 Acceptance. |
| Automated recovery tooling | `Production前なら必要` or `Phase16以降` | Recovery matters, but should not block review-only Step1 unless Submit/Execution is entered. |

Over-complexity notes:

- Human Review and Review-only Morning add real complexity. They are justified only because 4591 created a valid Safety event that should not be cleared or ignored.
- Review Pending vs authoritative Submit Pending is correct but delicate. The next phase must keep the boundary explicit.
- Broker alignment initially drifted toward comparing the entire demo account to Runtime Current. BF corrected that; the correction is purpose-aligned.

## 5. Runtime Acceptance Completeness

Accepted:

| Area | Status | Evidence |
|---|---|---|
| Step0 review-only readiness | `ACCEPTED` | BG: `STEP0_REVIEW_ONLY_READY` |
| Step1 SELL/HOLD review-only Morning | `ACCEPTED` | BH: `STEP1_REVIEW_ONLY_READY` |
| PM AI review execution | `ACCEPTED_FOR_REVIEW` | BH: 5 decisions, 4591 `EXIT`, review output generated |
| Human Review artifact consumption | `ACCEPTED_FOR_REVIEW` | BG/BH: valid artifact, Safety/Data Readiness connected |
| Broker authenticity for read-only evidence | `ACCEPTED_FOR_STEP0` | BF: `data_origin=BROKER_API`, mock/fixture false |

Not accepted:

| Area | Status | Reason |
|---|---|---|
| Full BUY Morning | `NOT_ACCEPTED` | Safety `HIGH_RISK_REVIEW` blocks BUY inference/planning. |
| Submit Scope | `NOT_ACCEPTED` | Review Pending is not authoritative Submit Pending. |
| Approval Apply | `NOT_ACCEPTED` | No apply path acceptance. |
| Broker Write | `NOT_ACCEPTED` | Explicitly blocked. |
| Execution / Fill / Current apply | `NOT_ACCEPTED` | No submit/execution run in BH. |
| Report after real submit/execution | `NOT_ACCEPTED` | Payload/report evidence exists, but not after full non-idempotent flow. |
| Multi-Day Validation | `NOT_ACCEPTED` | Lifecycle continuity across days is still unproven. |
| Production Ready | `NOT_ACCEPTED` | Requires additional production write, scheduler, notification, recovery, and runbook validation. |

## 6. Runtime State Machine Review

Formal design exists:

```text
IDLE
MARKET_DATA_READY
FEATURE_READY
CURRENT_STATE_LOADED
AI_INFERENCE_DONE
DAILY_PLAN_CREATED
PENDING_PROMOTED
APPROVAL_PENDING
APPROVED
SUBMITTING
SUBMITTED
POST_SEND_UNKNOWN
MONITORING_FILL
LEDGER_UPDATED
RECONCILED
REPORT_READY
REVIEW_REQUIRED
BLOCKED
HALT
```

Current review-only path:

```text
Data Readiness
↓
Review-only Morning
↓
Review Pending
↓
Human Review Output
```

Canonical trading path still requiring acceptance:

```text
Data Readiness
↓
Review-only Morning / full Morning
↓
Review Pending
↓
Submit Pending
↓
Execution
↓
Current
↓
Report
```

Assessment:

- The state machine is conceptually coherent.
- `Review Pending` is not yet a formally accepted transition into `Submit Pending`.
- `Submit Pending -> Execution -> Current -> Report` remains acceptance-unproven after BH.
- Therefore the state machine is contractually defined but only partially acceptance-evidenced.

## 7. Human Review Review

Human Review is necessary for Production operation when Safety emits a valid high-risk event and the system must not either:

- force-clear the event, or
- stop all operator-visible SELL/HOLD analysis.

Assessment:

| Item | Status |
|---|---|
| Review Contract | `PASS_WITH_CONDITIONS` |
| Review Artifact | `READY_FOR_CURRENT_EVENT` |
| Review Scope | `SELL/HOLD review-only, no trade authorization` |
| Review Expiration | `DEFINED` |
| Review Consumer | `Safety Decision and Data Readiness` |
| Safety connection | `PASS` |
| Data Readiness connection | `PASS` |

Remaining gap:

```text
Human confirmation/apply path from review evidence to authoritative Submit scope is not accepted.
```

This should be handled as Submit Scope Review, not silently folded into Review-only Morning.

## 8. Remaining Acceptance

Remaining Phase15 Acceptance appears to be:

1. Submit Scope Review
2. Approval / Human confirmation boundary
3. Execution Scope Review
4. Current apply / reconcile after execution
5. Report / notification payload after accepted execution/current path
6. Multi-Day Validation

Additional pre-production items, not necessarily Phase15 blockers:

- Production Broker Write validation
- Notification real delivery and delivery ledger
- Scheduler / launchd hardening
- Operator recovery/apply tooling
- Production runbooks
- Secret handling audit before write enablement

## 9. Completion Criteria Boundary

Do not conflate:

```text
Step1 review-only READY
```

with:

```text
Phase15 Complete
Production Ready
```

Phase15 Complete still requires:

- Runtime Reconstruction PASS.
- Runtime Acceptance PASS.
- No Phase15 blockers open.
- Non-idempotent boundaries documented and guarded.
- Evidence links available in reports/manifests.

Production Ready additionally requires:

- Production Broker Write validation.
- Real notification delivery.
- Scheduler hardening.
- Operator recovery tooling.
- Runbooks for review, unknown submit, broker divergence, current correction, valuation failure.
- Multi-day operation evidence.

## 10. Review Results

### 10.1 Phase15で達成したもの

- Hidden Runtime policy was exposed and moved into explicit contracts.
- Runtime stopped acting as the substitute for Candidate / Opportunity / PM / Safety decisions.
- Producer / Artifact / Consumer thinking became the default.
- Data Readiness became the entry gate before execution.
- Safety became fail-closed and action-scoped.
- Temporal freshness was formalized beyond single `as_of`.
- Broker evidence authenticity was made explicit.
- REVIEW_REQUIRED became an operational state through Human Review and review-only SELL/HOLD.

### 10.2 目的から逸脱したもの

- Full demo account alignment was initially over-applied to Runtime-owned Current. This was corrected in BF.
- Review-only scaffolding must be watched carefully so it does not become hidden SELL logic.
- Some reporting/evidence artifacts overlap; without an operator-facing hierarchy, evidence can become noisy rather than explanatory.

### 10.3 まだ未証明のもの

- Full BUY Morning.
- Submit Scope.
- Execution Scope.
- Current apply after execution.
- Report/notification after real submit/execution.
- Multi-day lifecycle continuity.
- Production Ready.

### 10.4 不要に複雑化したもの

- Review Pending vs Submit Pending is necessary but operationally fragile.
- Human Review artifact validation adds complexity, but is justified by the high-risk event.
- Evidence surfaces are numerous; later work should define a single operator entrypoint.

### 10.5 このまま進めて問題ないもの

- Proceeding to a design-only / review-only Submit Scope Review.
- Keeping BUY blocked while 4591 remains `HIGH_RISK_REVIEW`.
- Keeping Broker Write and Submit blocked.
- Treating SELL/HOLD review output as human review evidence, not an order.

## 11. Conditions

Purpose alignment passes only under these conditions:

1. Do not treat `STEP1_REVIEW_ONLY_READY` as full Morning readiness.
2. Do not promote Review Pending to authoritative Submit Pending without a separate Submit Scope Review.
3. Keep Runtime from adding hidden BUY/SELL decision rules in review-only scaffolding.
4. Keep Safety `REVIEW_REQUIRED` visible until a valid next state is accepted.
5. Keep Production Ready separate from Phase15 Complete.

## 12. Final Judgment

```text
PHASE15_PURPOSE_ALIGNMENT_PASS_WITH_CONDITIONS
```

Recommended next prefix:

```text
Phase15-BJ Runtime Acceptance Step2 Submit Scope Review Design-Only / Review-Only
```

Submit itself should still not be executed in the next prefix unless a later scope explicitly authorizes it.
